Master of Technology Thesis • 2026

An Integrated Machine Learning and Bioinformatics Pipeline for Lung Cancer Biomarker Discovery and Biosensor Translation

Author

Adhaar Kohli

Degree

Master of Technology (M.Tech) • 2026

Institution

Jaypee Institute of Information Technology, Noida, India

Abstract

This thesis develops LungVar-ML, an integrated bioinformatics pipeline that translates raw multi-omic data into a translatable biosensor for non-small cell lung cancer (NSCLC) biomarker detection. The pipeline harmonizes transcriptomic, somatic mutation, methylation, and copy-number data from 982 TCGA-NSCLC tumors. A consensus procedure reduces approximately 50,000 features to a panel of ~250 biomarkers. A two-level stacking ensemble achieves a cross-validated AUC of 0.913 and a concordance index of 0.821, outperforming other algorithms and retaining discrimination on external cohorts. Interpretability analysis identifies a proliferation-immune axis and links to STK11/KEAP1 co-mutation. The panel is translated into a circulating-miRNA biosensor design with high sensitivity, achieving a diagnostic AUC of 0.958.

Internal AUC-ROC

0.913

C-index

0.821

Biosensor AUC

0.958

Log-rank p-value

<0.0001

9-Stage Pipeline Methodology

1

Pan-Omic Data Acquisition

Gathering data from TCGA (LUAD/LUSC), GEO, and cBioPortal — 982 tumors, ~50,000 features across 5 omic layers.

2

Quality Control & Batch Correction

Standardizing data using ComBat for technical variation correction.

3

Per-Omic Feature Engineering

Processing RNA-seq, WES/MAF, Methylation, CNV, Clinical data with omic-specific tools.

4

Consensus Feature Selection

Four independent selectors (mRMR, LASSO, Boruta, Cox-PH) with majority vote → ~250 features.

5

Two-Level Stacking Ensemble Training

5 base learners (RF, XGBoost, SVM-RBF, ElasticNet, LightGBM) + LogReg meta-learner, stratified k-fold CV, SMOTE.

6

Risk-Score Generation & Patient Stratification

Calibrated risk scores stratify patients into low/intermediate/high risk groups.

7

Internal & External Validation

Hold-out sets + two independent GEO cohorts for transportability.

8

Tumor Microenvironment Deconvolution

CIBERSORTx and ESTIMATE scores for immune profiling.

9

Interpretation & Biosensor Translation

SHAP interpretability + Si-NWFET biosensor design for miRNA detection.

Model Performance

  • External Cohorts
  • Internal CV
AUC-ROCC-indexAccuracySensitivitySpecificity0.70.7750.850.9251

Risk Group Stratification

Low RiskIntermediateHigh Risk020406080Median Survival (months)

Biomarker Panel

250 features • 982 tumors

Transcriptomics (RNA-seq)

MKI67SPP1CEACAM5TOP2ACCNB1AURKAFOXM1COL11A1FN1VIMCDH2VEGFA+9

Genomics (WES)

TP53KRASEGFRALKROS1BRAFMETRETERBB2STK11KEAP1NF1+6

Epigenomics (Methylation)

CDKN2ARASSF1AFHITSHOX2CA9TMEM100

Copy Number Variations

MYCSOX2CDKN2ARB1PTENZEB1FN1SNAI2NAPSA

Circulating miRNAs

miR-21-5pmiR-155-5pmiR-210-3pmiR-205-5pmiR-1290miR-182-5pmiR-31-5pmiR-17-5pmiR-19a-3pmiR-486-5pmiR-126-3pmiR-34a-5p+5

ML & Bioinformatics Techniques

Stacking Ensemble (Random Forest, XGBoost, SVM-RBF, ElasticNet, LightGBM + LogReg meta)

Consensus Feature Selection (mRMR, LASSO, Boruta, Cox-PH)

Bayesian Hyperparameter Optimization (Optuna)

SMOTE & Cost-sensitive Class Weighting

SHAP & LIME Interpretability

Survival Analysis (Kaplan-Meier, Cox-PH, C-index, Time-dep AUC)

PCA & UMAP Dimensionality Reduction

Molecular Docking (AutoDock Vina)

Molecular Dynamics (GROMACS, MM-PBSA)

Network Analysis (STRING, Cytoscape, MCODE, GO, KEGG, Reactome)

Key Contributions

  • 1.Interpretable, externally validated, translatable pan-omic prognostic framework for NSCLC
  • 2.Robust multi-omic integration with consensus feature selection + two-level stacking
  • 3.Demonstrated biological coherence: proliferation-immune axis, STK11/KEAP1 co-mutation
  • 4.Pathway from prognostic signature to Si-NWFET biosensor for point-of-care diagnostics
  • 5.Reproducible pipeline via Docker containerization and Snakemake workflow management

Future Directions

  • Prospective multi-center clinical validation of LungVar-ML and miRNA biosensor
  • Physical fabrication and clinical testing of Si-NW FET biosensor panel
  • Integration of single-cell/spatial transcriptomics, ctDNA, radiomics, and imaging features
  • Clinician-facing decision support interface with risk scores + SHAP rationales
  • Methodology generalization to other cancer types